Market Place
Sourcing Support
Genmab Completes Tender Offer For Merus N.V. Shares
12 Dec 2025 //
PHARMIWEB
Genmab To Hold 2025 R&D Update And ASH Data Review Meeting
11 Dec 2025 //
GLOBENEWSWIRE
Genmab A/S Managers And Associates Engage In Share Transactions
01 Dec 2025 //
GLOBENEWSWIRE
Genmab to Participate in Chat at Citi Global Healthcare Conf
24 Nov 2025 //
GLOBENEWSWIRE
Genmab A/S Managers And Associates Engage In Share Transactions
20 Nov 2025 //
PHARMIWEB
Genmab Grants Restricted Stock Units And Warrants To Employees
20 Nov 2025 //
GLOBENEWSWIRE
Genmab Gets FDA Nod For Epkinly Combo In Follicular Lymphoma
18 Nov 2025 //
BUSINESSWIRE
Genmab Sees Capital Boost From Employee Warrant Exercise
18 Nov 2025 //
GLOBENEWSWIRE
Genmab Prices Notes Offering, Completes Loan Syndication
18 Nov 2025 //
GLOBENEWSWIRE
Genmab Sheds Another Clinical ADC From $1.8B Profoundbio Buy
17 Nov 2025 //
FIERCE BIOTECH
Genmab Discloses Details On Proposed Private Offering Of Notes
10 Nov 2025 //
GLOBENEWSWIRE
Genmab Announces Private Placement of Secured/Unsecured Notes
10 Nov 2025 //
GLOBENEWSWIRE
Genmab Announces Financial Results For The Nine Months Of 2025
06 Nov 2025 //
GLOBENEWSWIRE
Genmab Joins Fireside Chat at Jefferies Global Healthcare Conf
05 Nov 2025 //
GLOBENEWSWIRE
Genmab Presents Latest Blood Cancer Treatments at ASH 2025
03 Nov 2025 //
BUSINESSWIRE
Genmab Initiates Tender Offer For Merus N.V. Shares
21 Oct 2025 //
GLOBENEWSWIRE
Genmab Shows Rina-S Effectiveness In Advanced Endometrial Cancer
18 Oct 2025 //
GLOBENEWSWIRE
Genmab Reports Darzalex Net Sales in Q3 2025
14 Oct 2025 //
GLOBENEWSWIRE
Genmab Acquires Merus, Boosts Late-Stage Pipeline
30 Sep 2025 //
BUSINESSWIRE
Genmab Grants Restricted Stock Units And Warrants To Employees
25 Sep 2025 //
GLOBENEWSWIRE
Major Shareholder Announcement
23 Sep 2025 //
GLOBENEWSWIRE
Genmab Discards ADC from $1.8 B ProfoundBio Buy
17 Sep 2025 //
FIERCE BIOTECH
Genmab`s Capital Increase Due to Employee Warrant Exercise
09 Sep 2025 //
GLOBENEWSWIRE
Genmab A/S Share Transactions by Managerial Staff and Associates
09 Sep 2025 //
GLOBENEWSWIRE
Genmab Gets FDA Breakthrough Tag for Rina-S in Endometrial Cancer
26 Aug 2025 //
BUSINESSWIRE
Genmab to Join Morgan Stanley Global Healthcare Conference
26 Aug 2025 //
GLOBENEWSWIRE
Genmab Capital Increase Due to Employee Warrant Exercise
12 Aug 2025 //
GLOBENEWSWIRE
Genmab Ph3 EPCORE FL-1 Trial Meets Endpoints in Lymphoma Patients
08 Aug 2025 //
PHARMAWEB
Genmab Ph 3 EPCORE FL-1 Meets Endpoints in Follicular Lymphoma
07 Aug 2025 //
BUSINESSWIRE
Genmab Ph 3 EPCORE FL-1 Meets Dual Primary Endpoints in Lymphoma
07 Aug 2025 //
GLOBENEWSWIRE
Genmab Announces Financial Results for the First Half of 2025
07 Aug 2025 //
GLOBENEWSWIRE
Genmab Reports Q2 2025 Net Sales of DARZALEX® (daratumumab)
16 Jul 2025 //
GLOBENEWSWIRE
Genmab Announces Changes to its Executive Committee
01 Jul 2025 //
GLOBENEWSWIRE
Completion of Share Buy-back Program
30 Jun 2025 //
GLOBENEWSWIRE
Transactions in Connection with Share Buy-back Program
23 Jun 2025 //
GLOBENEWSWIRE
Genmab A/s Managerial Employees and Associates` Share Transaction
17 Jun 2025 //
GLOBENEWSWIRE
Genmab`s Epcoritamab Combo Shows High Response in DLBCL
15 Jun 2025 //
BUSINESSWIRE
Genmab grants Restricted Stock Units and Warrants to Employees
12 Jun 2025 //
GLOBENEWSWIRE
Transactions in Connection with Share Buy-back Program
10 Jun 2025 //
GLOBENEWSWIRE
Genmab`s Rin-S Shows Promise in Endometrial Cancer Trial
02 Jun 2025 //
BUSINESSWIRE
Transactions in Connection with Share Buy-back Program
02 Jun 2025 //
GLOBENEWSWIRE
Genmab to Join Chat at 46th Goldman Sachs Health Conference
27 May 2025 //
GLOBENEWSWIRE
Transactions in Connection with Share Buy-back Program
26 May 2025 //
GLOBENEWSWIRE
Endometrial Cancer Data on Genmab’s Elahere Rival Beat Forecast
23 May 2025 //
FIERCE BIOTECH
Genmab to Present Late-Stage Oncology Data at 2025 ASCO Meeting
22 May 2025 //
BUSINESSWIRE
Genmab to Join Fireside Chat at 2025 Jefferies Conference
21 May 2025 //
GLOBENEWSWIRE
Genmab`s Capital Increases Due to Employee Warrant Exercise
20 May 2025 //
GLOBENEWSWIRE
Transactions in Connection with Share Buy-back Program
19 May 2025 //
GLOBENEWSWIRE
Transactions in Connection with Share Buy-back Program
12 May 2025 //
GLOBENEWSWIRE
Genmab Announces Financial Results for the First Quarter of 2024
08 May 2025 //
GLOBENEWSWIRE
Transactions in Connection with Share Buy-back Program
05 May 2025 //
GLOBENEWSWIRE
Transactions in Connection with Share Buy-back Program
28 Apr 2025 //
GLOBENEWSWIRE
Transactions in Connection with Share Buy-back Program
22 Apr 2025 //
GLOBENEWSWIRE
Genmab reports Darzalex® Net Sales for Q1 2025
15 Apr 2025 //
GLOBENEWSWIRE
Transactions in Connection with Share Buy-back Program
14 Apr 2025 //
GLOBENEWSWIRE
Genmab A/S Share Capital Reduction
10 Apr 2025 //
GLOBENEWSWIRE
Transactions In Connection with Share Buy-back Program
07 Apr 2025 //
GLOBENEWSWIRE
Genmab A/S Managerial Employees` Transactions with Shares
01 Apr 2025 //
GLOBENEWSWIRE
Transactions in connection with share buy-back program
31 Mar 2025 //
GLOBENEWSWIRE
TIVDAK® approved by European Commission for Cervical Cancer
31 Mar 2025 //
GLOBENEWSWIRE
